Curetis NV (CURE) - Product Pipeline Analysis, 2018 Update

Curetis NV (CURE) - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME59289PD
  • |
  • Pages: 62
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company provides diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for cartridges, diseases such as implant and tissue infections, and pneumonia; and also used in the laboratory for multiplex polymerase chain reaction pcr diagnostics. Curetis serves medical, healthcare companies, biotechnology, contract research and pharmaceutical companies, among others. The company sells its products through a network of distributors located across Germany. It has its operations in in France, Switzerland, Netherlands, the UK, the US and Germany. Curetis is headquartered in Stuttgart, Germany.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Curetis NV

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Curetis NV Company Overview 6

Curetis NV Company Snapshot 6

Curetis NV Pipeline Products and Ongoing Clinical Trials Overview 6

Curetis NV-Pipeline Analysis Overview 9

Curetis NV-Key Facts 9

Curetis NV-Major Products and Services 10

Curetis NV Pipeline Products by Development Stage 11

Curetis NV Ongoing Clinical Trials by Trial Status 15

Curetis NV Pipeline Products Overview 17

Gyronimo Analyzer 17

Gyronimo Analyzer Product Overview 17

Next Generation Unyvero Implant & Tissue Infections Cartridge 18

Next Generation Unyvero Implant & Tissue Infections Cartridge Product Overview 18

Next-Generation Sequencing Assay-Microbial Infections 19

Next-Generation Sequencing Assay-Microbial Infections Product Overview 19

Unyvero A30 RQ Application Cartridge 20

Unyvero A30 RQ Application Cartridge Product Overview 20

Unyvero Analyzer 21

Unyvero Analyzer Product Overview 21

UNYVERO ANALYZER A30-CNS Infection 22

UNYVERO ANALYZER A30-CNS Infection Product Overview 22

UNYVERO ANALYZER A30-ICO 23

UNYVERO ANALYZER A30-ICO Product Overview 23

UNYVERO ANALYZER A30-RVP 24

UNYVERO ANALYZER A30-RVP Product Overview 24

Unyvero Analyzer A30 RQ 25

Unyvero Analyzer A30 RQ Product Overview 25

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel 26

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel Product Overview 26

Unyvero BCU Cartridge 27

Unyvero BCU Cartridge Product Overview 27

Unyvero BCU Cartridge Clinical Trial 28

Unyvero Cardiology Infection Cartridge 29

Unyvero Cardiology Infection Cartridge Product Overview 29

Unyvero CNS Infections Cartridge 30

Unyvero CNS Infections Cartridge Product Overview 30

Unyvero Extended Respiratory Infection Cartridge 31

Unyvero Extended Respiratory Infection Cartridge Product Overview 31

Unyvero HPN Catridge 32

Unyvero HPN Catridge Product Overview 32

Unyvero i60 Cartridge 33

Unyvero i60 Cartridge Product Overview 33

Unyvero IAI Cartridge 34

Unyvero IAI Cartridge Product Overview 34

Unyvero IJI Cartridge 35

Unyvero IJI Cartridge Product Overview 35

Unyvero IJI Cartridge Clinical Trial 36

Unyvero LRT55 Cartridge-Bronchial Lavage Samples 37

Unyvero LRT55 Cartridge-Bronchial Lavage Samples Product Overview 37

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples 38

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples Product Overview 38

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples Clinical Trial 39

Unyvero LRT55 Lower Respiratory Tract Cartridge 40

Unyvero LRT55 Lower Respiratory Tract Cartridge Product Overview 40

Unyvero P50 LRT Cartridge 41

Unyvero P50 LRT Cartridge Product Overview 41

Unyvero Pediatric Infections Cartridge 42

Unyvero Pediatric Infections Cartridge Product Overview 42

Unyvero Sepsis Host Response Cartridge 43

Unyvero Sepsis Host Response Cartridge Product Overview 43

Unyvero Sepsis Host Response Cartridge Clinical Trial 44

Unyvero Tuberculosis Cartridge 45

Unyvero Tuberculosis Cartridge Product Overview 45

Curetis NV-Key Competitors 46

Curetis NV-Key Employees 47

Curetis NV-Locations And Subsidiaries 48

Head Office 48

Other Locations & Subsidiaries 48

Recent Developments 49

Curetis NV, Recent Developments 49

Jun 07, 2018: Curetis Launches Unyvero System and LRT Cartridge for Lower Respiratory Tract Infections in the U.S. 49

May 18, 2018: Curetis Publishes Business and Financial Update for the First Quarter 2018 49

Apr 30, 2018: Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance For 2018 51

Apr 19, 2018: Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection Cartridge at ECCMID 2018 53

Apr 18, 2018: Curetis: Novel Products and Study Data to be Presented at ECCMID 2018 54

Apr 11, 2018: Curetis Establishes U.S. Scientific Advisory Board 54

Apr 04, 2018: Curetis'' Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority 56

Apr 03, 2018: Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge 57

Mar 14, 2018: Curetis Receives USPTO Notice of Allowance for Key Patent Covering Unyvero Technology 58

Mar 06, 2018: Curetis subsidiary Ares Genetics wins incubator stay in Silicon Valley 58

Appendix 59

Methodology 59

About GlobalData 62

Contact Us 62

Disclaimer 62

List of Figures

Curetis NV Pipeline Products by Equipment Type 7

Curetis NV Pipeline Products by Development Stage 11

Curetis NV Ongoing Clinical Trials by Trial Status 15

List of Tables

Curetis NV Pipeline Products and Ongoing Clinical Trials Overview 6

Curetis NV Pipeline Products by Equipment Type 7

Curetis NV Pipeline Products by Indication 8

Curetis NV Ongoing Clinical Trials by Trial Status 8

Curetis NV, Key Facts 9

Curetis NV, Major Products and Services 10

Curetis NV Number of Pipeline Products by Development Stage 11

Curetis NV Pipeline Products Summary by Development Stage 12

Curetis NV Ongoing Clinical Trials by Trial Status 15

Curetis NV Ongoing Clinical Trials Summary 16

Gyronimo Analyzer-Product Status 17

Gyronimo Analyzer-Product Description 17

Next Generation Unyvero Implant & Tissue Infections Cartridge-Product Status 18

Next Generation Unyvero Implant & Tissue Infections Cartridge-Product Description 18

Next-Generation Sequencing Assay-Microbial Infections-Product Status 19

Next-Generation Sequencing Assay-Microbial Infections-Product Description 19

Unyvero A30 RQ Application Cartridge-Product Status 20

Unyvero A30 RQ Application Cartridge-Product Description 20

Unyvero Analyzer-Product Status 21

Unyvero Analyzer-Product Description 21

UNYVERO ANALYZER A30-CNS Infection-Product Status 22

UNYVERO ANALYZER A30-CNS Infection-Product Description 22

UNYVERO ANALYZER A30-ICO-Product Status 23

UNYVERO ANALYZER A30-ICO-Product Description 23

UNYVERO ANALYZER A30-RVP-Product Status 24

UNYVERO ANALYZER A30-RVP-Product Description 24

Unyvero Analyzer A30 RQ-Product Status 25

Unyvero Analyzer A30 RQ-Product Description 25

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel-Product Status 26

Unyvero Analyzer A30 RQ-Immuno-Compromised Patient Panel-Product Description 26

Unyvero BCU Cartridge-Product Status 27

Unyvero BCU Cartridge-Product Description 27

Unyvero BCU Cartridge-External, Prospective, Multicenter Evaluation Comparing the Performance of the BCU Application Cartridge against the Performance of Conventional Microbiology Work-Up 28

Unyvero Cardiology Infection Cartridge-Product Status 29

Unyvero Cardiology Infection Cartridge-Product Description 29

Unyvero CNS Infections Cartridge-Product Status 30

Unyvero CNS Infections Cartridge-Product Description 30

Unyvero Extended Respiratory Infection Cartridge-Product Status 31

Unyvero Extended Respiratory Infection Cartridge-Product Description 31

Unyvero HPN Catridge-Product Status 32

Unyvero HPN Catridge-Product Description 32

Unyvero i60 Cartridge-Product Status 33

Unyvero i60 Cartridge-Product Description 33

Unyvero IAI Cartridge-Product Status 34

Unyvero IAI Cartridge-Product Description 34

Unyvero IJI Cartridge-Product Status 35

Unyvero IJI Cartridge-Product Description 35

Unyvero IJI Cartridge-Clinical Study of Unyvero IJI Cartridge for the Detection of Invasive Joint Infections 36

Unyvero LRT55 Cartridge-Bronchial Lavage Samples-Product Status 37

Unyvero LRT55 Cartridge-Bronchial Lavage Samples-Product Description 37

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Product Status 38

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Product Description 38

Unyvero LRT55 Cartridge-Tracheal Aspirate Samples-Clinical CE Performance Evaluation of Unyvero P55 Pneumonia Application 39

Unyvero LRT55 Lower Respiratory Tract Cartridge-Product Status 40

Unyvero LRT55 Lower Respiratory Tract Cartridge-Product Description 40

Unyvero P50 LRT Cartridge-Product Status 41

Unyvero P50 LRT Cartridge-Product Description 41

Unyvero Pediatric Infections Cartridge-Product Status 42

Unyvero Pediatric Infections Cartridge-Product Description 42

Unyvero Sepsis Host Response Cartridge-Product Status 43

Unyvero Sepsis Host Response Cartridge-Product Description 43

Unyvero Sepsis Host Response Cartridge-Bedside Versus Standard Microbiological Blood Culture Diagnostics: BEMIDIA Study 44

Unyvero Tuberculosis Cartridge-Product Status 45

Unyvero Tuberculosis Cartridge-Product Description 45

Curetis NV, Key Employees 47

Curetis NV, Other Locations 48

Curetis NV, Subsidiaries 48

Glossary 61

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Roche Innovatis AG

Biomed Labordiagnostik GmbH

AMODIA Bioservice GmbH

Curetis NV, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license

Single User License
USD 750 INR 53910
Site License
USD 1500 INR 107820
Corporate User License
USD 2250 INR 161730

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com